|
1 |
Facility and Engineering Non-Hazardous Control Requirements
This table was created by CSI Testing Inc. as a an educational tool for clients in the pharmaceutical community. This document provides a clear and concise summary of facility and engineering requirements for non-hazardous drug compounding.
|
140 |
|
2 |
Facility and Engineering Hazardous Control Requirements
This table was created by CSI Testing Inc. as a an educational tool for clients in the pharmaceutical community. This document provides a clear and concise summary of facility and engineering requirements for hazardous drug compounding.
|
399 |
|
3 |
Using Air, Surface, and Personnel Sampling Data as a Cost-Effective Quality Metric
This presentation begins with a general update on USP 797 from Eric Kastango and then goes into detail on cost-effective quality metrics.
|
345 |
|
4 |
Setting up a Program for Microbial Monitoring in the Pharmacy
Since USP Chapter was published two years ago, pharmacists and technicians have been working hard to meet the challenges of the USP chapter and to improve their sterile compounding operations.
|
371 |
|
5 |
A Review of pH and Osmolarity
Pharmacists have been extemporaneously
compounding medications to meet patient
needs for centuries. After the industrial
revolution, many compounding
functions that had been performed by pharmacists
were undertaken by pharmaceutical
manufacture
|
360 |
|
6 |
Compounding Containment Devices: Buyer be Aware
The risk of occupational exposure to chemicals used in the extemporaneous and batch compounding of human and vetrinary oral, topical, ophthalmic, vaginal, rectal, and parenteral products is significant.
|
356 |
Peer Network